Tuesday, Jul 01st
Last update03:06:18 AM GMT
Health Glance
Dr. Campbell is a medical doctor with a postgraduate degree in neurology. She worked as a neurologist and a neurosurgeon for several years before starting a family. When her first-born son was diagnosed autistic at the age of three, she was surprised to realize that her own profession had no answers…
Back in 1984, when she graduated from medical school, autism was an exceptionally rare disorder, with a prevalence of about 1 in 10,000.
The United States Government and its terrorist arm, the FDA, apparently have a monopoly on medical information that you’d better not challenge. Unapproved mobile apps are now a potential criminal venture. The FDA is proposing that it should be the supreme authority concerning the wonderful world of mobile medical applications. The corrupt agency says it doesn’t propose to oversee all apps – just those that “could present a risk to patients if the apps don’t work as intended.” This is the consummate, disjointed governmentspeak – a proposal that could be interpreted to mean whatever the Feds want it to mean at any point in time.
Surprising as it may seem, the way the present system works is that thousands of devices are routinely cleared for market without any of the clinical testing for safety or effectiveness that is required for prescription drugs.
"I thought that any medical device that was actually being put into people's bodies had been extensively tested before it was released to the public," said Ayers. Not exactly.
Regulators with the Food and Drug Administration have warned that Multaq, a cardiac drug Sanofi, has been linked with fatal heart problems in a clinical trial the company recently ended.
Multaq is prescribed to control atrial fibrillation, the most common type of irregular heartbeat which is found in about 2.2 million Americans. It is a condition in which the primary electrical impulse that causes the atria - the two upper chambers of the heart - to contract instead fires erratically, causing several other nodes, or electrical impulse points, to fire instead.
Johnson & Johnson said Thursday that it's reducing the maximum daily dose of its Extra Strength Tylenol pain reliever to lower risk of accidental overdose from acetaminophen, its active ingredient and the top cause of liver failure.
The company's McNeil Consumer Healthcare Division said the change affects Extra Strength Tylenol sold in the U.S. - one of many products in short supply in stores due to a string of recalls.
U.S. District Judge Royce Lamberth ruled the U.S. National Institutes of Health (NIH) guidelines on such research do not violate federal law and he dismissed a legal challenge to the funding.
Lamberth a year ago had halted the funding of the research. But he was reversed in a ruling by a U.S appeals court in April. His latest decision was largely based on the appeals court's reasoning and conclusions.
Child drugging has been a huge profitable market for Big Pharma, earning them $4.8 billion dollars a year. They have done everything in their power to convince the press, legislators and especially parents why children need to be put on drugs.
They claim that ADD/ADHD, depression, bipolar disorder, etc., are medical conditions, and consider them on par with cancer, diabetes, and heart disease. But in reality there is no actual evidence that proves that psychiatric disorders are indeed medical conditions. They simply diagnose a child by using a behavioral checklist.
Page 99 of 234
